Novel insulin receptor substrate 1 and 2 variants in breast and colorectal cancer

Oncology Reports

Volumn 30, Issue 4, 2013, Pages 1553-1560

  Esposito, Diana Liberata ^a   Verginelli, Fabio ^a   Toracchio, Sonia ^a,d   Mammarella, Sandra ^a   De Lellis, Laura ^a   Vanni, Cinzia ^b   Russo, Antonio ^c   Mariani Costantini, Renato ^a   Cama, Alessandro ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b Cardiology Department SS Annunziata Hospital   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; Colorectal cancer; Insulin receptor substrate 1; Insulin receptor substrate 2

Indexed keywords

ARGININE; ASPARAGINE; ASPARTIC ACID; CYSTEINE; GLUTAMINE; HISTIDINE; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; LEUCINE; PROLINE; SERINE;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CARCINOGENICITY; COLON CARCINOGENESIS; COLORECTAL CANCER; COMPUTER MODEL; CONTROLLED STUDY; EXON; FRAMESHIFT MUTATION; GENE INSERTION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; INTRON; IRS 1 GENE; IRS 2 GENE; MICROSATELLITE INSTABILITY; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA SPLICING;

BREAST NEOPLASMS; CACO-2 CELLS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; FEMALE; FRAMESHIFT MUTATION; GENETIC VARIATION; HCT116 CELLS; HT29 CELLS; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; MCF-7 CELLS; MUTAGENESIS, INSERTIONAL; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; SEQUENCE DELETION; SIGNAL TRANSDUCTION;

EID: 84882712329     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2626     Document Type: Article

References (38)

1. Sun XJ, Rothenberg P, Kahn CR, et al: Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352: 73-77, 1991.
2. Yamauchi T, Ueki K, Tobe K, et al: Growth hormone-induced tyrosine phosphorylation of EGF receptor as an essential element leading to MAP kinase activation and gene expression. Endocr J 45 (Suppl): S27-S31, 1998.
3. White MF and Yenush L: The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Curr Top Microbiol Immunol 228: 179-208, 1998.
4. Smith-Hall J, Pons S, Patti ME, et al: The 60 kDa insulin receptor substrate functions like an IRS protein (pp60IRS3) in adipose cells. Biochemistry 36: 8304-8310, 1997.
5. Fantin VR, Sparling JD, Slot JW, Keller SR, Lienhard GE and Lavan BE: Characterization of insulin receptor substrate 4 in human embryonic kidney 293 cells. J Biol Chem 273: 10726-10732, 1998.
6. White MF: IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 283: E413-E422, 2002.
7. Araki E, Lipes MA, Patti ME, et al: Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372: 186-190, 1994.
8. Withers DJ, Gutierrez JS, Towery H, et al: Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391: 900-904, 1998.
9. Slattery ML, Samowitz W, Curtin K, et al: Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev 13: 1206-1214, 2004.
10. Ding YC, McGuffog L, Healey S, et al: A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 21: 1362-1370, 2012.
11. Esposito DL, Aru F, Lattanzio R, et al: The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer. PLoS One 7: e36190, 2012.
12. Bommer GT, Feng Y, Iura A, et al: IRS1 regulation by Wnt/beta-catenin signaling and varied contribution of IRS1 to the neoplastic phenotype. J Biol Chem 285: 1928-1938, 2010.
13. Ramocki NM, Wilkins HR, Magness ST, et al: Insulin receptor substrate-1 deficiency promotes apoptosis in the putative intestinal crypt stem cell region, limits Apcmin/+ tumors, and regulates Sox9. Endocrinology 149: 261-267, 2008.
14. Parsons DW, Wang TL, Samuels Y, et al: Colorectal cancer: mutations in a signalling pathway. Nature 436: 792, 2005.
15. Bishehsari F, Mahdavinia M, Malekzadeh R, et al: Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin. Ann Oncol 17 Suppl 7: vii91-vii96, 2006.
16. Palmirotta R, Matera S, Curia MC, et al: Correlations between phenotype and microsatellite instability in HNPCC: implications for genetic testing. Fam Cancer 3: 117-121, 2004.
17. Bottomley WE, Soos MA, Adams C, et al: IRS2 variants and syndromes of severe insulin resistance. Diabetologia 52: 1208-1211, 2009.
18. Ng PC and Henikoff S: Predicting deleterious amino acid substitutions. Genome Res 11: 863-874, 2001.
19. Xi T, Jones IM and Mohrenweiser HW: Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Genomics 83: 970-979, 2004.
20. Almind K, Bjørbaek C, Vestergaard H, Hansen T, Echwald S and Pedersen O: Amino acid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 342: 828-832, 1993.
21. Laakso M, Malkki M, Kekäläinen P, Kuusisto J and Deeb SS: Insulin receptor substrate-1 variants in non-insulin-dependent diabetes. J Clin Invest 94: 1141-1146, 1994.
22. Imai Y, Fusco A, Suzuki Y, et al: Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 79: 1655-1658, 1994.
23. Ura S, Araki E, Kishikawa H, et al: Molecular scanning of the insulin receptor substrate-1 (IRS-1) gene in Japanese patients with NIDDM: identification of five novel polymorphisms. Diabetologia 39: 600-608, 1996.
24. Esposito DL, Mammarella S, Ranieri A, et al: Deletion of Gly723 in the insulin receptor substrate-1 of a patient with noninsulin-dependent diabetes mellitus. Hum Mutat 7: 364-366, 1996.
25. Whitehead JP, Humphreys P, Krook A, et al: Molecular scanning of the insulin receptor substrate 1 gene in subjects with severe insulin resistance: detection and functional analysis of a naturally occurring mutation in a YMXM motif. Diabetes 47: 837-839, 1998.
26. Celi FS, Negri C, Tanner K, et al: Molecular scanning for mutations in the insulin receptor substrate-1 (IRS-1) gene in Mexican Americans with type 2 diabetes mellitus. Diabetes Metab Res Rev 16: 370-377, 2000.
27. Esposito DL, Li Y, Vanni C, et al: A novel T608R missense mutation in insulin receptor substrate-1 identified in a subject with type 2 diabetes impairs metabolic insulin signaling. J Clin Endocrinol Metab 88: 1468-1475, 2003.
28. Abecasis GR, Altshuler D, Auton A, et al: A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073, 2010.
29. Bernal D, Almind K, Yenush L, et al: Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians. Diabetes 47: 976-979, 1998.
30. Butte NF, Voruganti VS, Cole SA, et al: Resequencing of IRS2 reveals rare variants for obesity but not fasting glucose homeostasis in Hispanic children. Physiol Genomics 43: 1029-1037, 2011.
31. Heinen CD, Richardson D, White R and Groden J: Microsatellite instability in colorectal adenocarcinoma cell lines that have full-length adenomatous polyposis coli protein. Cancer Res 55: 4797-4799, 1995.
32. Giannini G, Rinaldi C, Ristori E, et al: Mutations of an intronic repeat induce impaired MRE11 expression in primary human cancer with microsatellite instability. Oncogene 23: 2640-2647, 2004.
33. van der Heijden MS, Brody JR, Elghalbzouri-Maghrani E, Zdzienicka MZ and Kern SE: Does tumorigenesis select for or against mutations of the DNA repair-associated genes BRCA2 and MRE11?: considerations from somatic mutations in microsatellite unstable (MSI) gastrointestinal cancers. BMC Genet 7: 3, 2006.
34. Chang Q, Li Y, White MF, Fletcher JA and Xiao S: Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications. Cancer Res 62: 6035-6038, 2002.
35. Dearth RK, Cui X, Kim HJ, et al: Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2. Mol Cell Biol 26: 9302-9314, 2006.
36. Dearth RK, Cui X, Kim HJ, Hadsell DL and Lee AV: Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2. Cell Cycle 6: 705-713, 2007.
37. Houghton AM, Rzymkiewicz DM, Ji H, et al: Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med 16: 219-223, 2010.
38. Modica S, Morgano A, Salvatore L, et al: Expression and localisation of insulin receptor substrate 2 in normal intestine and colorectal tumours. Regulation by intestine-specific transcription factor CDX2. Gut 58: 1250-1259, 2009.